Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations.
Choi J, Yoon S, Kim D, Moon YW, Lee CH, Seo S, Cheon J, Gho YS, Kim C, Lee ER, Kim SY, Lee K, Ha JY, Park SR, Kim SW, Park KS, Lee DH.
Choi J, et al.
Am J Cancer Res. 2019 Aug 1;9(8):1708-1721. eCollection 2019.
Am J Cancer Res. 2019.
PMID: 31497352
Free PMC article.